About: Treatment of low-risk non-muscle-invasive bladder cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Treatment of low-risk non-muscle-invasive bladder cancer Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
rdfs:seeAlso	http://www.touchurology.com/articles/treatment-low-risk-non-muscle-invasive-bladder-cancer
Description	Low-risk non-muscle-invasive bladder cancer (NMIBC) accounts for approximately 50 % of newly diagnosed bladder cancer. It is defined by the European Organisation for Research and Treatment of Cancer (EORTC) risk tables and is characterised by low risk of both recurrence and progression. Transurethral resection of the bladder (TURB) is the crucial step in its management. The aim is to eradicate all tumours and establish an accurate diagnosis. Narrow-band imaging and fluorescence cystoscopy (photodynamic diagnosis [PDD]) detect more lesions. PDD also improves recurrence-free survival. Single immediate intravesical instillation after TURB is the standard of care in low-risk NMIBC since it prolongs time to recurrence. Some patients with small papillary recurrent low risk tumours may be observed or treated by office fulguration. All patients should be followed by regular cystoscopies. Results of the first cystoscopy three months after TURB is a surrogate marker for patient's prognosis Low-risk non-muscle-invasive bladder cancer (NMIBC) accounts for approximately 50 % of newly diagnosed bladder cancer. It is defined by the European Organisation for Research and Treatment of Cancer (EORTC) risk tables and is characterised by low risk of both recurrence and progression. Transurethral resection of the bladder (TURB) is the crucial step in its management. The aim is to eradicate all tumours and establish an accurate diagnosis. Narrow-band imaging and fluorescence cystoscopy (photodynamic diagnosis [PDD]) detect more lesions. PDD also improves recurrence-free survival. Single immediate intravesical instillation after TURB is the standard of care in low-risk NMIBC since it prolongs time to recurrence. Some patients with small papillary recurrent low risk tumours may be observed or treated by office fulguration. All patients should be followed by regular cystoscopies. Results of the first cystoscopy three months after TURB is a surrogate marker for patient's prognosis (en)
Title	Treatment of low-risk non-muscle-invasive bladder cancer Treatment of low-risk non-muscle-invasive bladder cancer (en)
skos:prefLabel	Treatment of low-risk non-muscle-invasive bladder cancer Treatment of low-risk non-muscle-invasive bladder cancer (en)
skos:notation	RIV/00064203:_____/12:8397!RIV13-MZ0-00064203
http://linked.open...avai/riv/aktivita	I
http://linked.open...avai/riv/aktivity	I
http://linked.open...iv/cisloPeriodika	1
http://linked.open...vai/riv/dodaniDat	2013
http://linked.open...aciTvurceVysledku	Babjuk, Marek Brisuda, Antonín
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Fakultní nemocnice v Motole
http://linked.open...dnocenehoVysledku	175046
http://linked.open...ai/riv/idVysledku	RIV/00064203:_____/12:8397
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	Conservative strategy; Follow-up; Intravesical chemotherapy; Low-risk carcinoma; Narrow-band imaging; Photodynamic diagnosis; Prognostic risk tables; Risk of recurrence and progression; Transurethral resection; Urothelial neoplasm (en)
http://linked.open.../riv/klicoveSlovo	Conservative strategy Low-risk carcinoma Narrow-band imaging Photodynamic diagnosis Prognostic risk tables Risk of recurrence and progression Transurethral resection Urothelial neoplasm Follow-up Intravesical chemotherapy
http://linked.open...odStatuVydavatele	GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV	[761B50773449]
http://linked.open...i/riv/nazevZdroje	European Urological Review
http://linked.open...in/vavai/riv/obor	FD
http://linked.open...ichTvurcuVysledku	2 (xsd:int)
http://linked.open...cetTvurcuVysledku	3 (xsd:int)
http://linked.open...UplatneniVysledku	2012
http://linked.open...v/svazekPeriodika	7
http://linked.open...iv/tvurceVysledku	Hrbáček, Jan Babjuk, Marek Brisuda, Antonín
issn	1758-3829
number of pages	5 (xsd:int)

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software